Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group, held its second extraordinary general meeting for FY2024. The meeting took place in Tianjin, China, with simultaneous video conferencing for international shareholders in Singapore. This gathering reflects the company’s commitment to engaging with its global shareholder base.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
